Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

900
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
900
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NK Cell Profiling: Expression of TIGIT and LAG3 as Immune Checkpoints in Advanced Endometriosis.

American journal of reproductive immunology (New York, N.Y. : 1989)·2026
Same author

An Autosomal Dominant <i>TUBB3</i> Mutation Associated With Congenital Fibrosis of the Extraocular Muscles Type 3 in an Iranian Family.

Basic and clinical neuroscience·2026
Same author

Propolis-carboxymethyl cellulose Janus nanoparticles as multifunctional bioactive additives in stirred yogurt.

Scientific reports·2026
Same author

Fibrous ingrowth: an overlooked cause of Ahmed Glaucoma Valve failure.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Neutrophil Plasticity and NETosis in Tumour Microenvironment: Tumour Evolution and Therapy Resistance.

Journal of immunology research·2026
Same author

Development and evaluation of analytical strategies for the monitoring of per- and polyfluoroalkyl substances from lithium-ion battery recycling materials.

Analytical and bioanalytical chemistry·2025

Related Experiment Video

Updated: Dec 27, 2025

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

764

Intraorbital Steroid Injection for Active Thyroid Ophthalmopathy.

Abbas Bagheri1,2, Mohammad Abbaszadeh2, Shahin Yazdani1,2

  • 1Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Journal of Ophthalmic & Vision Research
|February 26, 2020
PubMed
Summary

Orbital steroid injections effectively treat active thyroid ophthalmopathy in patients unresponsive to systemic steroids. This method improved clinical activity scores and lid retraction, offering a viable alternative treatment.

Keywords:
Lid RetractionOrbital InflammationProptosisSteroid InjectionGraves

More Related Videos

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.1K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

1.4K

Related Experiment Videos

Last Updated: Dec 27, 2025

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

764
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.1K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

1.4K

Area of Science:

  • Ophthalmology
  • Endocrinology

Background:

  • Thyroid ophthalmopathy (TO) is an autoimmune condition affecting the eye socket.
  • Systemic steroids are a common treatment but can lead to resistance, dependence, or complications.

Purpose of the Study:

  • To assess the efficacy of orbital steroid injections for active thyroid ophthalmopathy.
  • To evaluate this treatment in patients with systemic steroid resistance, dependence, or complications.

Main Methods:

  • A prospective case series of 17 patients (31 eyes) with active TO (Clinical Activity Score [CAS] ≥ 3).
  • Retroseptal injections of triamcinolone acetonide and dexamethasone were administered 3-4 times at monthly intervals.
  • Patients were monitored post-injection and for at least three months after the final dose.

Main Results:

  • Mean CAS significantly decreased from 5.2 to 1.6 post-treatment (P < 0.001).
  • 100% improvement in upper lid retraction and 68.2% in lower lid retraction were observed.
  • Exophthalmos improved by 1.2 mm; strabismus resolved in one patient. Ocular side effects were minimal.

Conclusions:

  • Orbital steroid injections are a safe and effective treatment for active thyroid ophthalmopathy.
  • This approach is particularly beneficial for patients with resistance or adverse effects from systemic steroids.